Your browser doesn't support javascript.
loading
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study.
DeFilipp, Zachariah; Ancheta, Richard; Liu, Ying; Hu, Zhen-Huan; Gale, Robert Peter; Snyder, David; Schouten, Harry C; Kalaycio, Matt; Hildebrandt, Gerhard C; Ustun, Celalettin; Daly, Andrew; Ganguly, Siddhartha; Inamoto, Yoshihiro; Litzow, Mark; Szer, Jeffrey; Savoie, Mary Lynn; Hossain, Nasheed; Kharfan-Dabaja, Mohamed A; Hamadani, Mehdi; Reshef, Ran; Bajel, Ashish; Schultz, Kirk R; Gadalla, Shahinaz; Gerds, Aaron; Liesveld, Jane; Juckett, Mark B; Kamble, Rammurti; Hashmi, Shahrukh; Abdel-Azim, Hisham; Solh, Melhem; Bacher, Ulrike; Lazarus, Hillard; Olsson, Richard; Cahn, Jean-Yves; Grunwald, Michael R; Savani, Bipin N; Yared, Jean; Rowe, Jacob M; Cerny, Jan; Chaudhri, Naeem A; Aljurf, Mahmoud; Beitinjaneh, Amer; Seo, Sachiko; Nishihori, Taiga; Hsu, Jack W; Ramanathan, Muthalagu; Alyea, Edwin; Popat, Uday; Sobecks, Ronald; Saber, Wael.
Affiliation
  • DeFilipp Z; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: zdefilipp@mgh.harvard.edu.
  • Ancheta R; Scripps Blood & Marrow Transplant Program, Scripps Green Hospital, La Jolla, California.
  • Liu Y; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Hu ZH; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Gale RP; Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom.
  • Snyder D; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
  • Schouten HC; Department of Hematology, Academische Ziekenhuis, Maastricht, The Netherlands.
  • Kalaycio M; Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Hildebrandt GC; Markey Cancer Center, University of Kentucky, Lexington, Kentucky.
  • Ustun C; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota.
  • Daly A; Tom Baker Cancer Centre, Calgary, Alberta, Canada.
  • Ganguly S; Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, Kansas.
  • Inamoto Y; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Litzow M; Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, Minnesota.
  • Szer J; Department Clinical Haematology and Bone Marrow Transplantation, Royal Melbourne Hospital, Victoria, Australia.
  • Savoie ML; Tom Baker Cancer Centre, Calgary, Alberta, Canada.
  • Hossain N; Stanford Health Care, Stanford, California.
  • Kharfan-Dabaja MA; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.
  • Hamadani M; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Reshef R; Blood and Marrow Transplantation Program and Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York.
  • Bajel A; Department Clinical Haematology and Bone Marrow Transplantation, Royal Melbourne Hospital, Victoria, Australia.
  • Schultz KR; Department of Pediatric Hematology, Oncology and Bone Marrow Transplant, British Columbia's Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.
  • Gadalla S; Division of Cancer Epidemiology & Genetics, NIH-NCI Clinical Genetics Branch, Rockville, Maryland.
  • Gerds A; Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Liesveld J; Department of Medicine, University of Rochester Medical Center, Rochester, New York.
  • Juckett MB; Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisconsin.
  • Kamble R; Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.
  • Hashmi S; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota; Department of Oncology, Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Abdel-Azim H; Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California.
  • Solh M; The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, Georgia.
  • Bacher U; Department of Hematology, Inselspital, Bern University Hospital, Switzerland; Interdisciplinary Clinic for Stem Cell Transplantation, University Cancer Center Hamburg, Hamburg, Germany.
  • Lazarus H; Seidman Cancer Center, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio.
  • Olsson R; Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.
  • Cahn JY; Department of Hematology, CHU Grenoble Alpes, Grenoble, France.
  • Grunwald MR; Carolinas Medical Center Blumenthal Cancer Center Stem Cell Transplant Program, Levine Cancer Institute, Charlotte, North Carolina.
  • Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Yared J; Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland.
  • Rowe JM; Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel.
  • Cerny J; Division of Hematology and Oncology, Department of Medicine, UMass Memorial Medical Center, Worcester, Massachusetts.
  • Chaudhri NA; Department of Oncology, Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Aljurf M; Department of Oncology, Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Beitinjaneh A; Department of Medicine, University of Miami, Miami, Florida.
  • Seo S; Department of Hematology & Oncology, National Cancer Research Center East, Chiba, Japan.
  • Nishihori T; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Hsu JW; Division of Hematology & Oncology, Department of Medicine, Shands HealthCare and University of Florida, Gainesville, Florida.
  • Ramanathan M; Division of Hematology and Oncology, Department of Medicine, UMass Memorial Medical Center, Worcester, Massachusetts.
  • Alyea E; Center of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Popat U; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, Texas.
  • Sobecks R; Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Saber W; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
Biol Blood Marrow Transplant ; 26(3): 472-479, 2020 03.
Article in En | MEDLINE | ID: mdl-31669399
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Limits: Adult / Humans Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Limits: Adult / Humans Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2020 Type: Article